Search
Close this search box.

ASTHMA

Patient coughing

ASTHMA STUDY

ELIGIBILITY & REQUIREMENTS

  • Aged 18 to 60 years old.
  • Confirmed diagnosis of asthma.

WHAT'S INVOLVED

  • The clinical trial will run for approximately 21 weeks
  • 15 clinic visits to the Institute for Respiratory Health at QEII Medical Centre, Nedlands
  • A full health check by our doctors and nurses
  • Reimbursement for travel expenses
  • Personalised health care with our doctors and nurses

STUDY OUTLINE

This Phase 1/2A clinical trial is investigating the use of an investigational medicine ARO-RAGE for the treatment of asthma. ARO-RAGE is a solution which will be inhaled using a nebuliser.

ARO-RAGE aims to block the expression of RAGE (a receptor in the lung), therefore may decrease inflammation and improve airflow in patients with asthma.

To find out if this trial is suitable for you please register below, or contact our Clinical Trials Team at clinicaltrials@resphealth.uwa.edu.au or phone 6151 0888.

PRINCIPAL INVESTIGATOR

Dr John Blakey

LOCATION

Level 2, 6 Verdun Street Nedlands (within the Harry Perkins Institute)

REGISTER YOUR INTEREST TODAY

* indicates required
Scroll to Top